1. Home
  2. TIC vs MESO Comparison

TIC vs MESO Comparison

Compare TIC & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIC
  • MESO
  • Stock Information
  • Founded
  • TIC 1991
  • MESO 2004
  • Country
  • TIC United States
  • MESO Australia
  • Employees
  • TIC N/A
  • MESO N/A
  • Industry
  • TIC
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TIC
  • MESO Health Care
  • Exchange
  • TIC Nasdaq
  • MESO Nasdaq
  • Market Cap
  • TIC 1.3B
  • MESO 1.3B
  • IPO Year
  • TIC N/A
  • MESO N/A
  • Fundamental
  • Price
  • TIC $11.04
  • MESO $15.17
  • Analyst Decision
  • TIC Hold
  • MESO Buy
  • Analyst Count
  • TIC 1
  • MESO 4
  • Target Price
  • TIC $11.50
  • MESO $18.00
  • AVG Volume (30 Days)
  • TIC 1.6M
  • MESO 314.4K
  • Earning Date
  • TIC 08-14-2025
  • MESO 08-28-2025
  • Dividend Yield
  • TIC N/A
  • MESO N/A
  • EPS Growth
  • TIC N/A
  • MESO N/A
  • EPS
  • TIC N/A
  • MESO N/A
  • Revenue
  • TIC $1,108,546,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • TIC $5.80
  • MESO $177.23
  • Revenue Next Year
  • TIC $5.77
  • MESO $314.04
  • P/E Ratio
  • TIC N/A
  • MESO N/A
  • Revenue Growth
  • TIC 9.12
  • MESO N/A
  • 52 Week Low
  • TIC $8.76
  • MESO $5.78
  • 52 Week High
  • TIC $14.28
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • TIC N/A
  • MESO 60.94
  • Support Level
  • TIC N/A
  • MESO $14.45
  • Resistance Level
  • TIC N/A
  • MESO $16.23
  • Average True Range (ATR)
  • TIC 0.00
  • MESO 0.57
  • MACD
  • TIC 0.00
  • MESO 0.10
  • Stochastic Oscillator
  • TIC 0.00
  • MESO 63.12

About TIC Acuren Corporation Common Stock

Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: